Cardiac Patients Knowledge and Use of Sublingual Glyceryl Trinitrate Article

Cardiac Patients' Knowledge and Use of Sublingual Glyceryl Trinitrate Article Cardiac Patients' Knowledge and Use of Sublingual Glyceryl Trinitrate by Fan, Mitchell Cooke â€" Article Example > The paper “ Cardiac Patients’ Knowledge and Use of Sublingual Glyceryl Trinitrate by Fan, Mitchell Cooke ”   is a spectacular variant of an article on health sciences medicine. The research was to examine the knowledge and use of sublingual glyceryl trinitrate by cardiac patients. This is the main concern for clinical diagnosis since a third of all hospitalizations are as a result of the cardiac condition called the coronary heart disease who risk premature deaths, and vascular events like myocardial infarction (McIntosh 2004, pp. 272). The study was also to look at the patients' characteristics that influence their level of knowledge and use regarding SLGTN. This research was important for the nursing practice and cardiac rehabilitation staff in facilitating education sessions for patients in acute rehabilitation and admission situations regarding SLGTN. This way the role of nurses in providing health care and cardiac rehabilitation will be improved to promote quality of life and long term survival of patients (Warrington et al 2003, pp. 124). The research most specifically targets the cardiac patients who are administered SLGTN sprays and tablets in the study hospital. The patients are supposed to have knowledge of storage, angina prevention and the status of the drug expiry. Literature ReviewAccording to AIHW (2004), Coronary Heart Disease (CHD) is the most common heart disease in Australia has been the one with a third majority principal diagnosis for hospital admissions (ABS 2006). Angina has been found as a common symptom for CHD and can be managed by the patients using SLGTN as a pain control (Liu et al 2006, p. 1 out 2). The research shows that people with angina pain can manage their condition by self-administration of SLGTN to reduce complications. The research found more people with this condition wanted to know about its treatment, control, causes, medication, and its effects on their everyday life (Weetch 2003, pp. 152). This is because people didn’ t have enough knowledge of the use of SLGTN in appropriation and safe administration (McGovern et al 2001, pp. 175). However, this is as far as European and American research is concerned with no specific Australian research in the past that has looked at the patient’ s use and knowledge of SLG TN. Other studies for other medications like nitro-glycerine for angina showed that patients had little knowledge of its use and storage (Fernandez et al 2007, pp. 56). The past researches in Australia have not been specific to the knowledge of patients on the use of SLGTN and as a result, there is a research gap that needs to be filled which brings us to the aims of this research. The first is to research on the patients’ level of knowledge and use of SLGTN and also the patients’ characteristics that influence the use and the level of knowledge of SLGTN. Patients might not be able to administer the drug by themselves if they lack prior knowledge on how to given the risk involved in dosage. Type of patients also differ in knowledge and use of the drug and as a result the ability to administer it on themselves. Some characteristics are likely to encourage or hinder the use of the drug either by the health personnel or self-administration by the cardiac patients.